कोशिश गोल्ड - मुक्त
GLP-1 launches inject over 2x rise in India's weight-loss market sales in '25
Business Standard
|January 08, 2026
Mounjaro tops revenue charts, recording ₹601 cr in sales within 9 months of launch
India’s anti-obesity market saw a significant growth in 2025 with sales surging 115 per cent on year, as new launches in the injectable glucagon-like peptide-1 (GLP-1) agonist space, such as tirzepatide and semaglutide, flew off the shelves.
Sales in the weight loss market soared to ₹1,230 crore in 2025, against ₹571 crore in 2024.
GLP-1 agonists are a class of medications that help regulate blood sugar, increase fullness (satiety), and slow stomach emptying, leading to weight loss and improved glucose control for type 2 diabetes and obesity. Among them, Eli Lilly’s Mounjaro (tirzepatide) topped the revenue charts, recording ₹601 crore in sales within nine months of its launch in March 2025, while Novo Nordisk’s Wegovy (semaglutide) saw overall sales of ₹61 crore in six months.
On the other hand, Ozempic, launched only last month in India has raked in ₹1 crore.
यह कहानी Business Standard के January 08, 2026 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Business Standard से और कहानियाँ
Business Standard
Govt may open bids to onboard 15K Nvidia GPUs
The Centre is likely to soon open another round of bidding to onboard about 12,000-15,000 B100 and B200 graphic processing units (GPUs) from Nvidia under the IndiaAI Mission, sources told Business Standard on Thursday.
2 mins
January 09, 2026
Business Standard
Journeys in the Chinese imperium
In The Edge of the Empire: A Family’s Reckoning with China Edward Wong, journalist with The New York Times, writes about his and his father’s journeys in and away from China and how they shaped their understanding of the country as well as of each other.
3 mins
January 09, 2026
Business Standard
India may face 500% US tariff over purchase of Russian oil
Trump backs Bill aimed at punishing countries buying Russian crude
2 mins
January 09, 2026
Business Standard
Review benefit illustration, premium table, surrender value clause before purchase
Even as overall grievances against life insurers stayed flat, complaints linked to unfair business practices (UFBP) rose, going from 23,335 in 2023-24 to 26,667 in 2024-25, an increase of 14.3 per cent, according to the Insurance Regulatory and Development Authority of India’s (Irdai) annual report for 2024-25.
2 mins
January 09, 2026
Business Standard
World's copper crunch likely to intensify on AI, defence spending
The race for artificial intelligence (AI) and surging defence spending are set to intensify a projected shortage of copper as producers struggle to expand, according to a new study by S&P Global.
2 mins
January 09, 2026
Business Standard
Indices fall 1% on tariff uncertainty
Indian equity benchmarks Sensex and Nifty posted their steepest one-day drop in more than four months amid heightened uncertainty over US trade tariffs.
2 mins
January 09, 2026
Business Standard
India likely to grow at 6.6% in FY27: UN
India’s economy is projected to grow at 6.6 per cent in 2026-27 (FY27), supported by resilient consumption and strong public investment, which should largely offset the adverse impact of higher US tariffs, the United Nations (UN) said on Thursday.
1 mins
January 09, 2026
Business Standard
Premiumisation may have driven Q3 realty growth
Top listed real estate developers are expected to deliver a healthy performance in terms of presales and earnings forthe third quarter of 2025-26 (Q3FY26), supported by festival demand, resilient buyer sentiment, steady launches, premium sales, and strong collections.
2 mins
January 09, 2026
Business Standard
Govt steps up efforts to attract FDI for GCCs, semicon units
In pursuit of its $1 trillion economy goal, the Uttar Pradesh (UP) government is stepping up efforts to attract foreign direct investment (FDI) in the Global Capability Centres (GCC) and semiconductor plants.
1 min
January 09, 2026
Business Standard
Health sector seeks tax relief, rationalised rates
Health care, medtech, and pharma companies have urged the government to use the Union Budget 2026-27 to ease tax pressures, boost domestic manufacturing, and step up investments in research, innovation, and preventive care.
2 mins
January 09, 2026
Listen
Translate
Change font size